MA46927A - Procédés de détection du cancer - Google Patents

Procédés de détection du cancer

Info

Publication number
MA46927A
MA46927A MA046927A MA46927A MA46927A MA 46927 A MA46927 A MA 46927A MA 046927 A MA046927 A MA 046927A MA 46927 A MA46927 A MA 46927A MA 46927 A MA46927 A MA 46927A
Authority
MA
Morocco
Prior art keywords
detection methods
cancer detection
cancer
methods
detection
Prior art date
Application number
MA046927A
Other languages
English (en)
French (fr)
Inventor
Robert Feldman
Melanie Mahtani
Original Assignee
Prime Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prime Genomics Inc filed Critical Prime Genomics Inc
Publication of MA46927A publication Critical patent/MA46927A/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
MA046927A 2016-11-22 2017-11-22 Procédés de détection du cancer MA46927A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662425549P 2016-11-22 2016-11-22

Publications (1)

Publication Number Publication Date
MA46927A true MA46927A (fr) 2019-10-02

Family

ID=62195635

Family Applications (1)

Application Number Title Priority Date Filing Date
MA046927A MA46927A (fr) 2016-11-22 2017-11-22 Procédés de détection du cancer

Country Status (8)

Country Link
US (1) US20200081008A1 (enExample)
EP (1) EP3544605A4 (enExample)
JP (2) JP2020511933A (enExample)
CN (1) CN110198711A (enExample)
CA (1) CA3044257A1 (enExample)
MA (1) MA46927A (enExample)
MX (1) MX2019006005A (enExample)
WO (1) WO2018098379A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3044257A1 (en) * 2016-11-22 2018-05-31 Prime Genomics, Inc. Methods for cancer detection
CN108830045B (zh) * 2018-06-29 2021-04-20 深圳先进技术研究院 一种基于多组学的生物标记物系统筛选方法
KR102211972B1 (ko) * 2018-08-02 2021-02-04 엑소젠 피티이. 엘티디 액체생검 다중 암 유전자 바이오마커를 이용한 유방암 조기진단 및 치료 후 모니터링 방법
US12631640B2 (en) 2019-03-03 2026-05-19 Purdue Research Foundation Systems and methods for identifying subtype, prognosis, and monitoring of breast cancer
CN111679076A (zh) * 2020-06-15 2020-09-18 吉林医药学院 一种用于检测cyclinD1和BCL-2抗体的检测试剂盒
JP2023534094A (ja) * 2020-06-16 2023-08-08 グレイル エルエルシー 無細胞rnaの分析方法
CN111979321B (zh) * 2020-08-26 2022-07-12 郑州大学第一附属医院 用于胰腺癌检查的基因标记物
EP4208712A4 (en) * 2020-09-01 2024-12-11 Oncodea Corporation PREDICTIVE DIAGNOSTIC TEST FOR EARLY DETECTION AND MONITORING OF DISEASE
CN115927610B (zh) * 2022-07-19 2024-11-05 武汉艾米森生命科技有限公司 检测foxo6基因中目标区域的甲基化水平的试剂在制备膀胱癌诊断产品中的应用
WO2025005966A1 (en) * 2023-06-29 2025-01-02 Edge Animal Health, Inc. Urine pcr assay and use thereof to diagnose and stage feline chronic kidney disease

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294349B1 (en) * 1999-03-01 2001-09-25 University Of Mississippi Medical Ctr. Method of diagnosing and monitoring malignant breast carcinomas
US6358683B1 (en) * 1999-06-03 2002-03-19 The Regents Of The University Of California Blood-based assays for breast cancer
JP2008073304A (ja) * 2006-09-22 2008-04-03 Gifu Univ 超音波乳房診断システム
GB201000688D0 (en) * 2010-01-15 2010-03-03 Diagenic Asa Product and method
US9624547B2 (en) * 2010-02-10 2017-04-18 The Regents Of The University Of California Salivary transcriptomic and proteomic biomarkers for breast cancer detection
WO2012005764A2 (en) * 2010-07-08 2012-01-12 Prime Genomics, Inc. System for the quantification of system-wide dynamics in complex networks
JP2014507160A (ja) * 2011-02-22 2014-03-27 カリス ライフ サイエンシズ ルクセンブルク ホールディングス エス.アー.エール.エル. 循環バイオマーカー
KR101335034B1 (ko) * 2011-08-25 2013-12-02 주식회사 바이오인프라 유방암 진단을 위한 엑소좀 내의 ANT2 mRNA의 이용방법
US20170175197A1 (en) * 2014-01-29 2017-06-22 Caris Mpi, Inc. Molecular profiling of immune modulators
EP3152579A4 (en) * 2014-06-04 2018-01-17 Atossa Genetics Inc. Molecular mammography
WO2016004387A1 (en) * 2014-07-02 2016-01-07 H. Lee Moffitt Cancer Center And Research Institute, Inc. Gene expression signature for cancer prognosis
CA3044257A1 (en) * 2016-11-22 2018-05-31 Prime Genomics, Inc. Methods for cancer detection

Also Published As

Publication number Publication date
CN110198711A (zh) 2019-09-03
EP3544605A1 (en) 2019-10-02
EP3544605A4 (en) 2020-11-25
JP2020511933A (ja) 2020-04-23
CA3044257A1 (en) 2018-05-31
JP2022163076A (ja) 2022-10-25
MX2019006005A (es) 2019-10-02
WO2018098379A1 (en) 2018-05-31
US20200081008A1 (en) 2020-03-12

Similar Documents

Publication Publication Date Title
IL285838A (en) Identification using spectroscopy
EP3443066A4 (en) METHOD FOR EARLY DETECTING CANCER
EP3589732A4 (en) DETECTION OF PROSTATE CANCER
EP3357000A4 (en) CANCER IDENTIFICATION SYSTEMS AND METHODS
PL3739299T3 (pl) Wykrywanie obiektów
EP3408402A4 (en) MAGNETIC ELECTROCHEMICAL DETECTION
DK3538864T3 (da) Mikrotom
LT3425055T (lt) Molekulinis naviko aptikimo/diagnostikos reagentas
MA55748A (fr) Procédés de détection d'aav
EP3923593C0 (en) AREA RECONNAISSANCE
EP3513579A4 (en) RECOGNITION OF AN EVENT LOCATION
DE112016000423T8 (de) Abschnittslinienerkennungsvorrichtung
EP3607066A4 (en) PROCEDURE FOR DETECTION OF LUNG CANCER
EP3407317C0 (en) Tamper detection
EP3426241A4 (en) METHOD FOR THE DIAGNOSIS OF CANCER
EP2965077A4 (en) METHOD OF CANCER DETECTION
EP3488238C0 (en) COLON CANCER COMBINATION TEST
EP3610036A4 (en) DETECTION CASCADES
EP3341496A4 (en) METHOD FOR DETECTING A CANCER RESIDUAL
BR112017007401A2 (pt) métodos de detecção específicos
EP3341425A4 (en) Polyvinyl butyral G-polylactide COPOLYMER
EP3440641C0 (en) FRAUD DETECTION
EP3320329A4 (en) SENSOR CONNECTIONS AND RELATED METHODS AND DEVICES
EP3347477A4 (en) COMPOSITIONS AND PROCEDURES FOR PROTEIN DETECTION
EP3637106A4 (en) LUNG CANCER DETECTION PROCEDURE